The expansion of continuous glucose monitoring technology into general wellness sectors is encountering skepticism from epidemiological researchers questioning its clinical efficacy for healthy adults.
Trial Findings
A 12-month observational study tracking non-diabetic cohorts using consumer sensors showed no statistically significant improvements in long-term metabolic health outcomes compared to standard dietary monitoring groups.
Data Interpretation Challenges
Clinicians note that normal physiological glycemic variability is frequently misinterpreted by consumers as actionable pathology, leading to unnecessary dietary restrictions and behavioral stress.